Portfolio, Branding and Growth Strategy: Developed portfolio architecture, brand positioning, and expansion strategies for multiple clients
Comprehensive Analyses & Market Research: Led multiple analytic and research engagements to drive strategic recommendations. Defined learning objectives and managed agency partnerships to generate insights on packaging, concepts, claims, and shopper & HCP behavior, driving strategic direction and business actions
Claims and Packaging Strategy: Led naming and package strategy, including corporate and brand logo development, structure, function, and correct use instructions for several brands, including a first-in-class OTC product
Amazon / eCommerce Strategy: Conducted competitive and performance analyses and developed Amazon and direct-to-consumer activation strategies for new brand launches
Innovation: Served as innovation lead, creating and validating concepts, identifying ingredients and advancing sourcing, overall project management, plus developing of retailer sell-in decks for several brands
On-Going Marketing Support: Acted as senior marketing lead for multiple brands across different companies, including leading DTC, ecomm, digital & social media marketing, business reporting, and innovation initiatives
Business Development
Divestitures: Led the divestiture process of 4 brands for 4 different consumer healthcare companies
Proactive Acquisition Strategies: Led acquisition strategic development, evaluated hundreds of potential target brands, and helped acquire assets for 3 clients
Company Strategy and Re-Branding: Conducted internal strategy sessions resulting in the rebranding and revision of corporate identity for 2 clients
Go-to-Market Business Models: Analyzed and determined the most profitable commercialization strategy for multiple clients, including firms looking to launch in the US and other clients looking to expand distribution in alternative channels
Manufacturing Sourcing: Helped consumer health organizations identify manufacturing sources
Strategic Fundraising: Led efforts on behalf of a client to explore strategic fundraising
Rx-to-OTC Switch
Strategic Development: Led multiple initiatives advancing a range of Rx-to-OTC switches, including ACNU exploration for a first-in-class switch; claims and labeling development for new indications across multiple clients; and development of business plans and sales forecasts for early-stage switch opportunities
Regulatory Switch Program Development: Assessed precedent switches to build benefit-risk profiles to inform switch strategy; Developed clinical program cost and timing plans, including probability-of-success analyses, to enable business decisions
Pre-Investigational New Drug (pIND) Support: Delivered end-to-end pIND support (i.e., IND number acquisition, Drug Facts label development, FDA briefing books, etc.) to secure FDA feedback on proposed switch development programs on 4 potential Rx-to-OTC switches
Switch Partnership Facilitation: Identified, evaluated, and engaged prospective partners for clients seeking to out-license Rx-to-OTC switch assets
Best-in-Class Guidance: Advised clients on best practices, investment needs, and organization skills requirements for Rx-to-OTC switches; Developed a global Rx-to-OTC commercialization playbook
Thought Leadership: through CHPA leadership, numerous podcasts and speaking engagements
